Industries > Pharma > Global Antibacterial Drugs Market 2019-2029

Global Antibacterial Drugs Market 2019-2029

Cephalosporins, Penicillins, Fluoroquinolones, Macrolides, Carbapenems and Others

PUBLISHED: 25 April 2019
PAGES: 297
SUBMARKET: Therapeutic Drugs

WOOCS 2.2.1

The global antibacterial drugs market is estimated to have reach $43bn in 2018 and is expected to grow at a CAGR of 2% in the first half of the forecast period. The Cephalosporins submarket held 28% of the global antibacterial drugs market in 2018.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 297-page report you will receive 144 tables and 105 figures– all unavailable elsewhere.

The 297-page report provides clear detailed insight into the global antibacterial drugs market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope

Global Antibacterial Drugs Market forecasts from 2019-2029

Revenue forecasts for the 6 leading submarkets from 2019-2029:
• Cephalosporins
• Penicillins
• Fluoroquinolones
• Macrolides
• Carbapenems
• Others

Revenue forecasts for the 43 leading marketed antibacterial drugs from 2019-2029:
Cephalosporins: Rocephin, Sulperazon, Ceftin/Zinnat, Meiact, Flomox, Teflaro, Zeftera, Ceftolozane-tazobactam, Ceftazidime-Avibactam
Penicillins: Generic amoxicillin, Augmentin, Zosyn/Tazocin, Unasyn, Generic amoxicllin-clavulanic acid, Amoxil
Fluoroquinolones: Avelox, Cravit, Vigamox, Ciprodex, Cipro/Ciprobay, Geninax, Defafloxacin
Macrolides: Biaxin/Clarith, Zithromax, Dalacin, Dificid, Solithromycin
Carbapenems: Invanz, Merrem/Meropen, Primaxin, Doribax
Other antibacterial drugs: Zyvox, Cubicin, Tygacil, TOBI/TIP, Solodyn, Vibativ, Sirturo, Tedizolid, Oritavancin, Dalbavancin, Nemonoxacin, Surotomycin

Revenue forecasts for the leading regional markets forecasted in this report are the following:
• North America
• Europe
• Asia-Pacific
• RoW

Each regional market is further segmented by the 6 leading submarkets.

Revenue forecasts for the leading national markets forecasted in this report are the following:
• The US
• Japan
• Italy
• France
• The UK
• Spain
• Germany
• China
• India
• Brazil
• Russia
• South Korea

Global Antibacterial Drugs Market 2019-2029

This report discusses the selected leading companies:
• Adenium Biotech ApS,
• Allecra Therapeutics GmbH
• AstraZeneca
• Bayer
• BioVersys AG
• Eli Lilly
• GlaxoSmithKline (GSK)
• Merck & Co.
• Novartis
• Pfizer

Analysis of the strengths, weaknesses as well as the opportunities and threats of the antibacterial drugs industry and market

Coverage of antibacterial drug candidates in the R&D pipeline. Discussions of research and development – see progress in this industry, finding technological, clinical and commercial outlooks and opportunities

• Key Questions Answered by this Report:
• Gain forecasts from 2019 to 2029 for the overall world market and its leading submarkets, as well as those for prominent national markets.
• Explore the regulatory landscape for leading regional and national markets, as well as expected developments for the period 2019-2029.
• Identify drug development trends that will affect market participants from 2019 to 2029. This report contains SWOT and STEP analysis for the forecast period.
• See discussions of companies developing, manufacturing and marketing antibiotics, exploring products, technologies, R&D, partnerships, M&A and outlooks.

Visiongain’s study is intended for anyone requiring commercial analyses for the Global Antibacterial Drugs Market. You find data, trends and predictions.

Buy our report today Global Antibacterial Drugs Market 2019-2029: Cephalosporins, Penicillins, Fluoroquinolones, Macrolides, Carbapenems and Others.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Download sample pages

Complete the form below to download your free sample pages for Global Antibacterial Drugs Market 2019-2029

Download sample pages

Complete the form below to download your free sample pages for Global Antibacterial Drugs Market 2019-2029

Latest Pharma news

“Global Vaccine Contract Manufacturing market set to grow to $3,831.7m by 2025” says new Visiongain report

Major fluctuations in demand are seen in the case of influenza, as was seen during pandemics over the last decade. Unexpectedly, the Coronavirus or COVID-19 outbreak that started from Wuhan, China, has spread across continents, affecting various industries globally.

08 April 2020


Visiongain’s analysis indicates that total revenue on Tuberculosis Treatment Drugs Market will be $1,080 million in 2020 due to the World Health Organization strong commitment towards ending TB leading to increase in funding for the research and development both in developed as well and under-developed markets

Due to maturity of generic drug market, companies are moving away from generics drug into therapeutic market by building strong portfolio for development of anti-tuberculosis drug emphasizing all types of TB cases.

06 April 2020


The Global Wound Care Market Is Set to Boom, Particularly in Emerging Economies

The global wound care market is big, and only set to grow bigger.  Currently, estimates show a CAGR of 4.6% in the years to come, with the overall market growing from US$19.8 billion in 2019 to US$24.8 billion by 2024.  The industry is ripe with opportunity, with that growth coming from several factors – but most especially growth in emerging …

30 March 2020


“The global nasal drug delivery technology market is estimated to have reached $44,385 million in 2019” says new Visiongain report

Nasal Sprays segment held the largest market share of the global nasal drug delivery technology market in 2019.

30 March 2020